Literature DB >> 24831869

[Changing the therapeutic goal in critically ill patients. Ethical analysis of a surgical case].

R J Jox1, L Ney.   

Abstract

We report on a 32-year-old patient, who developed septic shock, toxic shock-like syndrome, and multiple organ failure following nectrotizing fasciitis. Amputations had to be performed on all extremities. Subsequently, she developed secondary sclerosing cholangitis. Treatment goals had to be reassessed, since long-term survival seemed doubtful and, in the best case, burdened with severe handicap. We discuss the evaluation of the treatment goals, utilizing a structured model of goal-setting. In the first step the treatment goal is identified based on the patient's wishes. This goal's realistic achievability is verified considering scientific evidence and medical experience. The benefit of the aspired goal is set in relation to risks and burden of the necessary treatment measures in a third step. The resulting benefit-risk ratio must be evaluated by the patient or her representative. Treatment goals have to be reevaluated if the assessment of achievability or the benefit-risk ratio are disadvantageous. In this case, the initial therapeutic goal was retained. After an extraordinarily prolonged and complex therapy including reconstructive surgery the patient is now living independently at home.

Entities:  

Mesh:

Year:  2014        PMID: 24831869     DOI: 10.1007/s00113-013-2455-5

Source DB:  PubMed          Journal:  Unfallchirurg        ISSN: 0177-5537            Impact factor:   1.000


  6 in total

1.  A new law on advance directives in Germany.

Authors:  U Wiesing; R J Jox; H-J Hessler; G D Borasio
Journal:  J Med Ethics       Date:  2010-12       Impact factor: 2.903

2.  Sclerosing cholangitis in critically ill patients: an important and easily ignored problem based on a German experience.

Authors:  Ting Lin; Kai Qu; Xinsen Xu; Min Tian; Jie Gao; Chun Zhang; Ying Di; Yuelang Zhang; Chang Liu
Journal:  Front Med       Date:  2014-01-10       Impact factor: 4.592

3.  Secondary sclerosing cholangitis: a comparison to primary sclerosing cholangitis.

Authors:  Andrea A Gossard; Paul Angulo; Keith D Lindor
Journal:  Am J Gastroenterol       Date:  2005-06       Impact factor: 10.864

Review 4.  Secondary sclerosing cholangitis.

Authors:  Petra Ruemmele; Ferdinand Hofstaedter; Cornelia M Gelbmann
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2009-05       Impact factor: 46.802

Review 5.  [End-of-life decisions, powers of attorney, and advance directives].

Authors:  R J Jox; H-J Hessler; G D Borasio
Journal:  Nervenarzt       Date:  2008-06       Impact factor: 1.214

6.  Medical futility at the end of life: the perspectives of intensive care and palliative care clinicians.

Authors:  Ralf J Jox; Andreas Schaider; Georg Marckmann; Gian Domenico Borasio
Journal:  J Med Ethics       Date:  2012-05-05       Impact factor: 2.903

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.